Stockholders' Equity (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended
	Jan. 07, 2019	Apr. 30, 2019	Apr. 30, 2018	Apr. 30, 2019	Apr. 30, 2018	Dec. 01, 2018	Nov. 30, 2018	Nov. 27, 2018	Oct. 26, 2018	Jul. 31, 2018	Mar. 27, 2017	Feb. 09, 2017	Jan. 18, 2017
Common stock issued		60,362,163		60,362,163					4,830,000	22,430,121		2,179,989	1,117,011
Acquisition in HDS													51.00%
Shares of common stock, obligated to issue													4,830,000
Common stock payable, Shares				1,238,517
Common stock payable, Amount				$ 201,294
Net (loss) attributable to noncontrolling interests		$ (839,419)	$ (103,794)	(1,199,822)	$ (313,261)
Investment in subsidiary by noncontrolling interest		44,020	$ 213,403	228,789	$ 213,403
Non-controlling interest		$ 21,958,757		$ 21,958,757						$ (5,576,272)
Series I Convertible Preferred Stock
Convertible preferred stock, shares authorized		6,000		6,000						6,000
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001						$ 0.001
Convertible preferred stock, shares issued		0		0						6,000
Convertible preferred stock shares issued value										$ 1
Series H Convertible Preferred Stock
Common stock issued upon conversion of preferred stock		25,200,000		25,200,000
Convertible preferred stock, shares authorized		109,000		109,000						109,000
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001						$ 0.001
Convertible preferred stock, shares issued		0		0						63,000	63,000
Convertible preferred stock shares issued value										$ 3	$ 3,000,000
Regentys Series A Redeemable Convertible Preferred Stock [Member]
Convertible preferred stock, shares authorized		2,793,192		2,793,192						2,793,192
Convertible preferred stock, par value (in dollars per share)		$ 0.0001		$ 0.0001						$ 0.0001
Convertible preferred stock shares issued value
Olaregen Series A Preferred Stock [Member]
Convertible preferred stock, shares authorized		592,683		592,683						0
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001						$ 0.001
Convertible preferred stock, shares issued		592,683		592,683						0
Convertible preferred stock shares issued value
Hema Diagnostic Systems, LLC
Net (loss) attributable to noncontrolling interests				(122,692)
Investment in subsidiary by noncontrolling interest				$ 133,679
B-H Sanford, LLC
Common stock issued upon conversion of preferred stock						25,200,000
Salvo
Common stock issued upon conversion of preferred stock							3,354,645
Moscato
Common stock issued upon conversion of preferred stock							3,276,000
Remain To Be Issued
Common stock issued										349,545
Olaregen
Non-controlling interest								$ (11,999,559)
LOI Terms	Pursuant to the Company’s acquisition of Olaregen on January 7, 2019 to acquire a 51% interest, the Company was issued 3,282,632 shares of Olaregen common stock. As of January 31, 2019, Olaregen had a total of 5,648,819 shares of common stock and 592,683 Series A voting preferred stock for a total of 6,241,502 total voting shares outstanding. As such, there are 2,958,870 of shares that belong to non-controlling interest shareholders which represents a 47.41% non-controlling interest.
Regentys
Non-controlling interest	$ (9,870,762)
LOI Terms	Pursuant to the Company’s acquisition of Regentys on January 7, 2019 to acquire a 51% interest, the Company was issued 12,048,161 shares of Regentys common stock. As of January 31, 2019, Regentys had a total of 18,623,278 shares of common stock and 2,793,192 Series A voting preferred stock for a total of 21,416,470 total voting shares outstanding. As such, there are 9,368,309 of shares that belong to non-controlling interest shareholders which represents a 43.74% non-controlling interest.
Net Purchase Price
Common stock issued													5,947,431
After Closing
Common stock issued													420
At Closing
Common stock issued													1,117,011
Post Reverse Stock Split
Common stock issued													4,830,000